Skip to main content

Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference

CAMBRIDGE, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will host in-person 1x1 investor meetings at the 2023 Wedbush PacGrow Healthcare Conference.

Wedbush PacGrow Healthcare Conference
1x1 Investor Meetings: August 8-9, 2023
Location: Lotte Palace Hotel, New York, NY

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  222.90
+0.34 (0.15%)
AAPL  273.80
-0.81 (-0.30%)
AMD  198.52
-10.65 (-5.09%)
BAC  54.66
-0.16 (-0.28%)
GOOG  298.77
-8.96 (-2.91%)
META  652.96
-4.19 (-0.64%)
MSFT  478.83
+2.44 (0.51%)
NVDA  170.91
-6.81 (-3.83%)
ORCL  179.04
-9.61 (-5.09%)
TSLA  466.84
-23.04 (-4.70%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.